HIK Hikma Pharmaceuticals PLC

22.22USD1687.00 GBp · LSE+0.12%Mkt Cap: 4.60B USDP/E: 12.88

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. Th…